Minang, Rico M.

HRN: 29-17-97  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/22/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
06/22/2026
06/28/2026
IV
500mg
Q8
H.pylori Infection
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: